Search Results
David Lee of Health Canada on fast tracking orphan drugs at World Orphan Drug Congress USA
VQ 2013 Ottawa: An Introduction to Proposed Orphan Drug Framework - David K. Lee, Health Canada
Eric Gervais of Medunik Canada on Canadian orphan drug market at World Orphan Drug Congress USA 2013
Rare disease and orphan drugs: industry executives at World Orphan Drug Congress USA
Orphan drug discoveries & academic centers of excellence at World Orphan Drug Congress USA
Orphan drugs and rare diseases: pharma executives at the World Orphan Drug Congress USA 2011
NIH, EURORDIS and more on globalizing orphan drug access at World Orphan Drug Congress USA 2013
World Orphan Drug Congress USA 2013 event highlights
Yann Le Cam of EURORDIS on EU rare disease treatment at World Orphan Drug Congress USA
Andrew Callos of Pfizer on sustainable business in rare disease at World Orphan Drug Congress USA
The Annual Cost of Orphan Drugs
FDA Basics: Timothy Cote - Office of Orphan Products Development
